Robert Fortino to guide them toward lasting health, vitality, and sustainable weight loss
The injectable tirzepatide studied in SURMOUNT trials and approved by the FDA as Mounjaro and Zepbound is not the same as the compounded ODT
The oral form may be a particularly good fit if: You're newly diagnosed with type 2 diabetes and want to avoid injections You have prediabetes and are trying to prevent progression to T2D You've had an aversion to injections that has delayed starting treatment Your HbA1c and weight goals can be addressed together It may be less ideal if you already take multiple morning medications, travel frequently with disrupted routines, or have a condition affecting gastric motility
Weight loss typically begins within 2-4 weeks, and cardiac benefits (blood pressure reduction, improved lipid profiles) emerge over 8-12 weeks
Change one variable for 3 to 5 days only, log the time you took your injection, the meal composition, portion size, and whether you walked after eating, then compare symptom intensity and timing
